Analysis of serum lysophosphatidylethanolamine levels in patients with non-alcoholic fatty liver disease by liquid chromatography-tandem mass spectrometry-Reference-Cited by-同舟云学术

Analysis of serum lysophosphatidylethanolamine levels in patients with non-alcoholic fatty liver disease by liquid chromatography-tandem mass spectrometry

Published:2020-10-22 Issue:1 Volume:413 Page:245-254
ISSN:1618-2642
Container-title:Analytical and Bioanalytical Chemistry
language:en
Short-container-title:Anal Bioanal Chem

Author:

Yamamoto Yusuke,Sakurai Toshihiro,Chen Zhen,Furukawa Takayuki,Gowda Siddabasave Gowda B.,Wu Yue,Nouso Kazuhiro,Fujii Yuki,Yoshikawa Yuki,Chiba Hitoshi,Hui Shu-Ping^ORCID

Funder

Japanese Society for the Promotion of Science KAKENHI Grants

Publisher

Springer Science and Business Media LLC

Subject

Biochemistry,Analytical Chemistry

Link

https://link.springer.com/content/pdf/10.1007/s00216-020-02996-9.pdf

Reference32 articles.

1. Makide K, Kitamura H, Sato Y, Okutani M, Aoki J. Emerging lysophospholipid mediators, lysophosphatidylserine, lysophosphatidylthreonine, lysophosphatidylethanolamine and lysophosphatidylglycerol. Prostaglandins Other Lipid Mediat. 2009;89:135–9.

2. Makide K, Uwamizu A, Shinjo Y, Ishiguro J, Okutani M, Inoue A, et al. Novel lysophospholipid receptors: their structure and function. J Lipid Res. 2014;55:1986–95.

3. Kurano M, Kano K, Hara M, Tsukamoto K, Aoki J, Yatomi Y. Regulation of plasma glycero-lysophospholipid levels by lipoprotein metabolism. Biochem J. 2019;476:3565–81.